Search research articles
Contact Us
Filters
Showing results (31-40 of 107) with videos related to
Page
of 11
Sort By:
Clinical Neurology and Neurosurgery
|
January 4, 2011
The expression of ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (E-NPP1) is correlated with astrocytic tumor grade
Indra Aerts, Jean-Jacques Martin, Peter Paul De Deyn, et al.
Neuromuscular Disorders : NMD
|
January 26, 2007
Distribution of glucocorticoid receptor alpha and beta subtypes in the idiopathic inflammatory myopathies
Jan L De Bleecker, Boel De Paepe, Veerle L Vervaet, et al.
Rejuvenation Research
|
April 30, 2010
Altered serum glycomics in Alzheimer disease: a potential blood biomarker?
Cuiying Chitty Chen, Sebastiaan Engelborghs, Sylviane Dewaele, et al.
Journal of Alzheimer'S Disease : JAD
|
April 5, 2018
Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort
Ellis Niemantsverdriet, Bart F E Feyen, Nathalie Le Bastard, et al.
Neuromuscular Disorders : NMD
|
October 17, 2003
Identification of novel GDAP1 mutations causing autosomal recessive Charcot-Marie-Tooth disease
Nadia Ammar, Eva Nelis, Luciano Merlini, et al.
Journal of Alzheimer'S Disease : JAD
|
March 19, 2019
Validation of the Erlangen Score Algorithm for Differential Dementia Diagnosis in Autopsy-Confirmed Subjects
Charisse Somers, Piotr Lewczuk, Anne Sieben, et al.
International Journal of Geriatric Psychiatry
|
December 4, 2004
The Middelheim Frontality Score: a behavioural assessment scale that discriminates frontotemporal dementia from Alzheimer's disease
Peter Paul De Deyn, Sebastiaan Engelborghs, Jos Saerens, et al.
European Journal of Epidemiology
|
February 5, 2004
Case-control study of environmental risk factors for Parkinson's disease in Belgium
Philippe Pals, Bart Van Everbroeck, Bart Grubben, et al.
Journal of Alzheimer'S Disease : JAD
|
February 1, 2013
Amyloid pathology influences aβ1-42 cerebrospinal fluid levels in dementia with lewy bodies
Sylvie Slaets, Nathalie Le Bastard, Jessie Theuns, et al.
Neurobiology of Aging
|
April 13, 2007
Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
Sebastiaan Engelborghs, Karen De Vreese, Tom Van de Casteele, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 107) with videos related to
Sort By:
Page
of 11
Clinical Neurology and Neurosurgery
|
January 4, 2011
The expression of ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (E-NPP1) is correlated with astrocytic tumor grade
Indra Aerts, Jean-Jacques Martin, Peter Paul De Deyn, et al.
Neuromuscular Disorders : NMD
|
January 26, 2007
Distribution of glucocorticoid receptor alpha and beta subtypes in the idiopathic inflammatory myopathies
Jan L De Bleecker, Boel De Paepe, Veerle L Vervaet, et al.
Rejuvenation Research
|
April 30, 2010
Altered serum glycomics in Alzheimer disease: a potential blood biomarker?
Cuiying Chitty Chen, Sebastiaan Engelborghs, Sylviane Dewaele, et al.
Journal of Alzheimer'S Disease : JAD
|
April 5, 2018
Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort
Ellis Niemantsverdriet, Bart F E Feyen, Nathalie Le Bastard, et al.
Neuromuscular Disorders : NMD
|
October 17, 2003
Identification of novel GDAP1 mutations causing autosomal recessive Charcot-Marie-Tooth disease
Nadia Ammar, Eva Nelis, Luciano Merlini, et al.
Journal of Alzheimer'S Disease : JAD
|
March 19, 2019
Validation of the Erlangen Score Algorithm for Differential Dementia Diagnosis in Autopsy-Confirmed Subjects
Charisse Somers, Piotr Lewczuk, Anne Sieben, et al.
International Journal of Geriatric Psychiatry
|
December 4, 2004
The Middelheim Frontality Score: a behavioural assessment scale that discriminates frontotemporal dementia from Alzheimer's disease
Peter Paul De Deyn, Sebastiaan Engelborghs, Jos Saerens, et al.
European Journal of Epidemiology
|
February 5, 2004
Case-control study of environmental risk factors for Parkinson's disease in Belgium
Philippe Pals, Bart Van Everbroeck, Bart Grubben, et al.
Journal of Alzheimer'S Disease : JAD
|
February 1, 2013
Amyloid pathology influences aβ1-42 cerebrospinal fluid levels in dementia with lewy bodies
Sylvie Slaets, Nathalie Le Bastard, Jessie Theuns, et al.
Neurobiology of Aging
|
April 13, 2007
Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
Sebastiaan Engelborghs, Karen De Vreese, Tom Van de Casteele, et al.
Page
of 11